Picton Mahoney Asset Management’s Oaktree Acquisition Corp III Life Sciences Warrant OACCW Stock Holding History

Picton Mahoney Asset Management’s Portfolio OACCW Stock Details OACCW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.1K	Hold	15,000	–	–	﹤0.01%	1076
2026 Q1	$11.3K	Hold	15,000	–	–	﹤0.01%	996
2025 Q4	$12.4K	Hold	15,000	–	–	﹤0.01%	942
2025 Q3	$11K	Hold	15,000	–	–	﹤0.01%	781
2025 Q2	$13K	Hold	15,000	–	–	﹤0.01%	683
2025 Q1	$11K	Buy	+15,000	New	+$11.4K	﹤0.01%	627

Other funds holding OACCW

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

AIMCA

Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.57% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return

GAM

Gritstone Asset Management Bethesda, Maryland $104M AUM 5.96% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.36B AUM 25.57% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Picton Mahoney Asset Management's OACCW Position: Q2 2026 in Review

Picton Mahoney Asset Management held its Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) position steady in Q2 2026 at 15,000 shares worth $14.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1076.

Picton Mahoney Asset Management first reported a position in OACCW in Q1 2025 and has held it in 6 quarters since. 9 funds tracked by Wall St. Rank hold OACCW as of Q2 2026.

Picton Mahoney Asset Management held 15,000 shares of Oaktree Acquisition Corp III Life Sciences Warrant worth $14.1K as of Q2 2026.
Picton Mahoney Asset Management left its Oaktree Acquisition Corp III Life Sciences Warrant share count unchanged in Q2 2026.
Oaktree Acquisition Corp III Life Sciences Warrant made up ﹤0.01% of Picton Mahoney Asset Management's portfolio in Q2 2026, its #1076 holding.
Picton Mahoney Asset Management first reported a position in Oaktree Acquisition Corp III Life Sciences Warrant in Q1 2025 and has held it in 6 quarters since.
9 funds tracked by Wall St. Rank held Oaktree Acquisition Corp III Life Sciences Warrant as of Q2 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.